Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma (2023)
Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma (2023) is organized by Healthcare Made Practical (HMP) Global.
Release Date: May 1, 2023
Expiration Date: July 30, 2024.
Description:
To be eligible for credit, participants must complete the educational activity, complete the 5-question post-test with a minimum score of 70%, and complete the activity evaluation form. Upon completing the activity, there will be instructions on how to complete the evaluation and print a certificate or other documentation of credit.
Learning Objectives:
After participating in this activity, learners should be better able to:
• Evaluate the mechanisms, efficacy, safety, and indications of approved TKIs for the treatment of HCC
• Assess clinical efficacy and safety data for approved and emerging TKIs and combination regimens
• Develop treatment strategies for HCC that include evidence-based therapeutic selection and adverse event management to optimize treatment outcomes.
Additional details will be posted as soon as information is available.